Immunomodulating effects of the anti-viral agent Silibinin in liver transplant patients with HCV recurrence

摘要

BackgroundSilibinin has been shown to have anti-HCV activity and immune-modulating properties by regulating dendritic cell (DC) function. DCs are antigen-presenting cells that, together with regulatory T cells (Treg), play a pivotal role in controlling alloimmune, as well as anti-HCV immune responses.